Robert Casey actually said...

key among these challenges is reaching agreement with regulators about determining the appropriate efficacy endpoints to support approval of innovative medicines for rare diseases.

Context

Emphasizes the need for regulatory agreement on efficacy endpoints for rare disease drug approvals.

04/04/2022

https://www.congress.gov...

More Robert Casey Quotes

View All Robert Casey Quotes